These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 20807613
1. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing? Kopp JB, Winkler CA, Nelson GW. Semin Nephrol; 2010 Jul; 30(4):409-17. PubMed ID: 20807613 [Abstract] [Full Text] [Related]
2. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K. Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188 [Abstract] [Full Text] [Related]
10. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Nelson GW, Freedman BI, Bowden DW, Langefeld CD, An P, Hicks PJ, Bostrom MA, Johnson RC, Kopp JB, Winkler CA. Hum Mol Genet; 2010 May 01; 19(9):1805-15. PubMed ID: 20124285 [Abstract] [Full Text] [Related]
11. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians. Tayo BO, Kramer H, Salako BL, Gottesman O, McKenzie CA, Ogunniyi A, Bottinger EP, Cooper RS. Int Urol Nephrol; 2013 Apr 01; 45(2):485-94. PubMed ID: 22956460 [Abstract] [Full Text] [Related]
12. Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report. Reeves-Daniel AM, Iskandar SS, Bowden DW, Bostrom MA, Hicks PJ, Comeau ME, Langefeld CD, Freedman BI. Am J Kidney Dis; 2010 May 01; 55(5):e21-4. PubMed ID: 20116156 [Abstract] [Full Text] [Related]
15. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJ. Br J Haematol; 2011 Nov 01; 155(3):386-94. PubMed ID: 21910715 [Abstract] [Full Text] [Related]
16. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW. Nephrol Dial Transplant; 2009 Nov 01; 24(11):3366-71. PubMed ID: 19567477 [Abstract] [Full Text] [Related]
17. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR. Science; 2010 Aug 13; 329(5993):841-5. PubMed ID: 20647424 [Abstract] [Full Text] [Related]
18. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Gopalakrishnan I, Iskandar SS, Daeihagh P, Divers J, Langefeld CD, Bowden DW, Hicks PJ, Rocco MV, Freedman BI. Hum Pathol; 2011 Feb 13; 42(2):291-4. PubMed ID: 21074826 [Abstract] [Full Text] [Related]
19. Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease. Palmer ND, Ng MC, Hicks PJ, Mudgal P, Langefeld CD, Freedman BI, Bowden DW. PLoS One; 2014 Feb 13; 9(2):e88273. PubMed ID: 24551085 [Abstract] [Full Text] [Related]